Analysts Set Quince Therapeutics, Inc. (NASDAQ:QNCX) Target Price at $8.00
Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) has earned a consensus recommendation of “Buy” from the seven analysts that are currently covering the company, MarketBeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average twelve-month price objective […]
